The Malaria Vaccine Developed by the University of Oxford, UK, Gets Praises as a New Breakthrough Vaccine

JEMBER PORTAL – The potential malaria vaccine has been shown to be effective in infant trials in Africa.

Trials vaccine The malaria suggests that possibility someday vaccine able to reduce the number of deaths from mosquito-borne diseases that kill up to half a million children each year.

Reported JEMBER PORTAL from Aljazeera, according to the researcher who led the experiment, vaccine malaria called R21 / Matrix-M was developed by scientists at the University Oxford The UK demonstrated efficacy of up to 77 percent in a year-long trial of 450 children in Burkina Faso.

Also Read: Firli Bahuri Called Azis Syamsuddin the Mastermind of the Meeting of KPK Investigators and the Mayor of Tanjung Balai

Pioneer vaccine malaria R21 / Matrix-M led by Adrian Hill, director Oxford‘s Jenner Institute and also one of the principal investigators behind vaccine Oxford-AstraZeneca for Covid-19.

Adrian Hill said it currently plans to carry out the final phase of trials on about 4,800 children aged between five months and three years in four countries around the world. Africa.

“This (vaccine malaria) was more effective than previously reported. The World Health Organization wants 75 percent vaccine effective. This is the first time someone has surpassed that level. “

Also Read: Denny Darko Predicts Nagita Slavina’s Middle Heart Will Be Born With This Condition

“Most importantly, this (vaccine malaria) can be produced on a large scale. So far, vaccine monitored safe. ” said Adrian Hill.

– .